Author(s): S. Bhavanisha Rithiga, S. Shanmugasundaram

Email(s): drsundaram@gmail.com

DOI: 10.5958/2231-5659.2021.00002.3   

Address: S. Bhavanisha Rithiga, S. Shanmugasundaram*
Department of Biotechnology, Sri Shakthi Institute of Engineering and Technology, Chinniyampalayam, Coimbatore-641062, Tamil Nadu India.
*Corresponding Author

Published In:   Volume - 11,      Issue - 1,     Year - 2021


ABSTRACT:
COVID-19, is a newly spread pandemic disease and is primarily transmitted through nasal droplets which then causes mild to severe respiratory illness. Now this has been the major challenge to the world to tackle and save the lives of people without a proper vaccine. Therefore, there is an urgent need to screen for antiviral bioactive compounds to inhibit COVID 19 development. Among others, the major viral protease is an important target as this enzyme plays an important role in the development of the virus. We were particularly looking for compounds from fruits that are capable of binding to the COVID19 major protease. Morin, a pentahydroxyflavone is commonly present in guava, tea, kiwi and strawberry. It has been shown to have antiviral, antibacterial and antioxidant properties. Hence, the compound Morin was virtually screened for its ability to bind to major 3CL protease (Mpro) of COVID19. The active site of the enzyme has dyad amino acids; HIS41 and CYS 145. This compound binds to HIS41 in the active site of the protease. The binding ability was studied using AutodockVina. The binding ability was compared to a synthetic ligand N3 which is already complexed with the main protease with the PDB Id: 7BQY. While the binding efficiency of N3 is -4.6 kcal /mole, it is -7.6 kcal /mole for Morin. Also the LIPINSKI analysis has shown its drug like character. The ADMET analysis has shown that it has no genotoxicity and low drug induced toxicity. Owing to its presence in fruits like strawberry, it could well be a prophylactic medication.


Cite this article:
S. Bhavanisha Rithiga, S. Shanmugasundaram. Virtual Screening of Pentahydroxyflavone – A Potent COVID-19 Major Protease Inhibitor. Asian J. Res. Pharm.Sci.2021;11(1):7-14. doi: 10.5958/2231-5659.2021.00002.3


1.        Malik YS et.al.  Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Veterinary Quarterly. 40; 2020: 68-76.

2.        Shivom, Goswami S, Pal N, Singh RP, Singh A, Kumudhavalli MV. A Meticulous Interpretation on a Sanguinary Disease COVID-19. Res. J. Pharma. Dosage Forms and Tech. 12; 2020:231-233.

3.        Mankar SD, Jadhav RS, Gaikwad K. Corona Viruses - Current Knowledge - A Review. Research J. Science and Tech. 12; 2020: 163-166.

4.        Rajashree GD, Abhijit NS, Sahil SB. Novel Corona Virus: One Biological Disaster of 2020. Research J. Science and Tech. 12; 2020: 147-156.

5.        Wang, Y., Wang, Y., Chen, Y., and Qin, Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of medical virology. 92; 2020: 568-576.

6.        Rodríguez-Morales, AJ, MacGregor K, Kanagarajah S, and Patel D. Going global–Travel and the 2019 novel coronavirus.  Travel medicine and infectious disease. 33; 2020:101578.

7.        Akshay R. Yadav, Shrinivas K. Mohite. A Novel Approach for Treatment of COVID-19 with Convalescent Plasma. Res. J. Pharma. Dosage Forms and Tech. 12; 2020:227-230.

8.        Dipak Nalawade, R. K. Godge, S. D. Magar. Analytical Method Development and Validation of Ritonavir: A Review. Research J. Science and Tech. 12; 2020: 157-162.

9.        Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV).  Bioscience trends.  14; 2020: 69-71.

10.      Pandey P, Jitendra Subhash Rane, Aroni Chatterjee, Abhijeet Kumar, Rajni Khan, Amresh Prakash and Shashikant Ray Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in-silico study for drug development. Journal of Biomolecular Structure and Dynamics. 2020:  DOI:10.1080/07391102.2020.1796811

11.      Hong EH, Song JH, Kim SR, Cho J, Jeong B, Yang H, and Chang SY. Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has Anti-inflammatory Effect in Influenza-infected Mice.  Immune Network. 20; 2020:

12.      Turshudzhyan, A. Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy. Cureus 12; 2020: 5.

13.      Nam GS, Lee, KS, and Nam KS. Morin hydrate inhibits platelet activation and clot retraction by regulating integrin αIIbβ3, TXA2, and cAMP levels. European Journal of Pharmacology. 865; 2019: 172734.

14.      Berman H, Henrick K, Nakamura H, and Markley JL. The worldwide Protein Data Bank (wwwPDB): ensuring a single, uniform archive of PDB data. Nucleic acids research, 35; 2007: D301-D303

15.      Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K,  Li  F, Jiang  R, Yang X, You T, Liu X, and Yang H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 582; 2020: 7811.      

16.      Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., ... and Wang, J. PubChem substance and compound databases. Nucleic acids research, 44; 2016 :1213

17.      Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T., andYelekçi, K. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. 2020:  1-13

18.      Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J, and Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J. 21; 2002: 3213–3224

19.      DeLano WL. Pymol: An open-source molecular graphics tool. CCP4. Newsletter on protein crystallography, 40; 2002: 82-92.

20.      Chagas CM, Moss S, and Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. International journal of pharmaceutics, 549; 2018:133-149

21.      Yang H, Sun L, Li W, Liu G, and Tang Y. In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts. Front Chem. 2018; 6: 129.

22.      Jo S, Kim S, Shin DH, and Kim MS. Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of enzyme inhibition and medicinal chemistry, 35; 2020: 145-151

23.      Hsia CW, Wu MP, Velusamy M, Hsia CH, Chou DS, Tsai CL, and Sheu JR. (2018). Novel therapeutic agent against platelet activation in vitro and arterial thrombosis in vivo by morin hydrate. International Journal of Molecular Sciences, 19; 2018: 2386.

24.      Kulkarni, AD, and Belgamwar VS. Influence of novel carrier Soluplus® on aqueous stability, oral bioavailability, and anticancer activity of Morin hydrate. Drying Technology. 37; 2019:  1143-1161

25.      Forli S, Huey R, Pique ME, Sanner, MF, Goodsell DS, and Olson AJ. Computational protein–ligand docking and virtual drug screening with the AutoDock suite. Nature protocol.11;2016: 905-919

26.      Sasikumar R, Govindasamy M, Chen S, Liu YC, Ranganathan P, Rwei S. Electrochemical determination of morin in Kiwi and Strawberry fruit samples using vanadium pentoxide nano-flakes. Journal of Colloid and Interface Science. 504; 2017: 626-632

Recomonded Articles:

Author(s): Mohd. Yaqub Khan, Maryada Roy, Brijesh Kumar Saroj, Sudhakar Dubey, Vineet Kumar Sharma

DOI: 10.5958/2231-5659.2015.00019.3         Access: Open Access Read More

Author(s): Lakshmi Prasanna J., Deepthi B., Rama Rao N.

DOI:         Access: Open Access Read More

Author(s): Namdeo Shinde, Nagesh Aloorkar, Ajit Kulkarni, Bhaskar Bangar, Suyog Sulake, Pratik Kumbhar

DOI:         Access: Open Access Read More

Author(s): Beatrice Y. Danladi, P. Geetha

DOI: 10.5958/2231-5659.2017.00031.5         Access: Open Access Read More

Author(s): Yogita R. Indalkar, Nayana V. Pimpodkar, Puja S. Gaikwad, Anita S. Godase

DOI: 10.5958/2231-5659.2016.00010.2         Access: Open Access Read More

Author(s): Muhammed Jameel VP, Ravikumar, Narayanaswamy VB

DOI: 10.5958/2231-5659.2016.00017.5         Access: Open Access Read More

Author(s): Ameena Samreen, Mohammed Riyaz, Amtul Asiya, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5659.2017.00007.8         Access: Open Access Read More

Author(s): Amol P. Suryawanshi, Dattatraya M. Shinkar, R.B. Saudagar.

DOI: 10.5958/0975-4377.2015.00013.0         Access: Open Access Read More

Author(s): D.M. Shinkar, Rohan S. Gadakh, R.B. Saudagar

DOI: 10.5958/2231-5659.2016.00015.1         Access: Open Access Read More

Author(s): Sunity Singh, Himanshu Joshi

DOI:         Access: Open Access Read More

Author(s): Amit Roy, Dayananda Bhoumik, Ram Kumar Sahu, Jaya Dwivedi

DOI:         Access: Open Access Read More

Author(s): Rajendra Jangde

DOI:         Access: Open Access Read More

Author(s): A. Sowmya, T. Ananthi

DOI:         Access: Open Access Read More

Author(s): Rupali Yevale, Manisha Sharma, Dhanshree Kakde, Nilofar Khan, Kirteebala Pawar

DOI: 10.5958/2231-5659.2018.00020.6         Access: Open Access Read More

Author(s): Smita S. Aher, Vaishali D. Sangale, Ravindra B. Saudagar

DOI: 10.5958/2231-5659.2016.00020.5         Access: Open Access Read More

Author(s): Smita Kolhe, Praveen Chaudhari, Dhananjay More

DOI:         Access: Open Access Read More

Author(s): Chinedu Fred Anowi, Uyai Umanah, A.U. Emezie, AU Utoh-Nedosa

DOI:         Access: Open Access Read More

Author(s): Shraddha. B. Patil, Bhavana. U. Jain, Manish Kondawar

DOI: 10.5958/2231-5659.2019.00020.1         Access: Closed Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231-5659 


Recent Articles




Tags